Change in variability of glucose daily profile by switching insulin glargine to insulin degludec in patients with diabetes -prospective open-label observational trial-
Latest Information Update: 11 Apr 2018
At a glance
- Drugs Insulin degludec (Primary) ; Insulin glargine (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 03 Apr 2018 Status changed from active, no longer recruiting to completed.
- 13 Mar 2013 New trial record